Summsl'y CD4 is a membrane glycoprotein on T lymphocytes that binds to the same peptide:major histocompatibility complex (MHC) class II molecule recognized by the antigen-specific receptor (TCR), thereby stabilizing interactions between the TCR and peptide:MHC class II complexes and promoting the localization of the src family tyrosine kinase p56 lck into the receptor complex. Previous studies identified a solvent-exposed loop on the class II 82 domain necessary for binding to CD4 and for eliciting CD4 coreceptor activity. Here, we demonstrate that a second surfaceexposed segment of class II is also critical for CD4 function. This site is in the ce2 domain, positioned in single class II heterodimers in such a way that it cannot simultaneously interact with the same CD4 molecule as the 82 site. The ability of mutations at either site to diminish CD4 function therefore indicates that specifically organized CD4 and/or MHC class II oligomers play a critical role in coreceptor-dependent T cell activation.
C
D4 is an integral membrane glycoprotein that functions as a coreceptor for c~/8 TCRs specific for MHC class II molecule:peptide complexes (1) (2) (3) . It is able to bind to MHC class II proteins expressed on cell surfaces (4, 5) and can interact simultaneously with the TCR and MHC class II during T cell interactions with antigen-presenting cells (6) (7) (8) (9) , stabilizing interactions between these molecules.
In addition, CD4 promotes the localization of the src family tyrosine kinase p56 ~k in the receptor complex (10, 11) . These two functions of CD4 regulate this molecule's contribution to antigen-specific thymic selection (12) and peripheral T cell activation (13, 14) . In T cells restricted by MHC class I molecules, CD8 performs functions similar to those of CD4 in MHC class II-restricted T cells (15, 16) .
MHC class II glycoproteins that interact with CD4 are heterodimers consisting of two non-covalently associated integral membrane polypeptide chains, oe and 8 (17, 18) . Both chains fold to form two distinct protein domains, with the highly polymorphic c~1 and ~1 domains combining to form a single membrane-distal antigen-binding region (19, 20) . Conversely, the membrane-proximal domains are relatively nonpolymorphic and consist of typical immunoglobulin-like domains that are frequently involved in receptor:counterreceptor interactions between hematopoietic cells.
Previous studies identified a solvent-exposed loop on the membrane-proximal 82 domain of class II molecules that is necessary for binding to CD4 and for eliciting CD4 coreceptor activity (21, 22) . Here, we demonstrate that a second surfaceexposed segment of the class II heterodimer located in the ce2 domain is also critical for CD4 function. This site is positioned in such a way that it does not appear able to simultaneously interact with the same CD4 molecule as the 82 site. These results impact on our understanding of coreceptordependent TCR complex formation during T cell activation, indicating the importance of organized CD4 and/or MHC class II oligomerization. The class II 82 and ce2 regions that interact with CD4 are brought next to one mother in the recently described crystallographic structure of the class II "dimer of dimers" (20) , suggesting an intriguing molecular model for this oligomerization event.
#g) using calcium phosphate coprecipitation (22, 25) . Homogenous populations of cells expressing high levels of wild-type or mutant AtriA/3 a heterodimers were selected by antibody-mediated magnetic bead sorting (22) . The structural integrity of mutant A~A~ d molecules was determined by antibody dilution assays (26) using the mAbs K24-199 (27) (specific for polymorphic residues in the otl domain), MK-D6 (28) (specific for polymorphic residues in the/31 domain), and M5/114 (29) (specific for a/$1 epitope of assembled a/B heterodimers). Transfected L cells were maintained in DMEM containing the same additives as described above for KPMI 1640 at 37~ and 10% CO2.
Mutagenesis. Mutations were generated either by the gapped heteroduplex method (22, 30) for S125G, S127T, V128A, G131A, Y133S, and ~E137A.V142A, or by PCK and splicing by overlap extension (22, 31) . PCR and splicing by overlap extension conditions were as follows: 1 min at 94~ 1 min at 40~ 1 min at 50~ 2 min at 72"C for 30 cycles followed by one cycle of 7 min at 72~ in a DNA thermal cycler (Ericomp, Inc., San Diego, CA). Mutant cDNAs were subcloned into the EcoKI site of the expression vector PeEXV-3 (32), and sequenced from double-stranded templates either by dideoxynucleotide sequencing using Sequenase version 2.0 T7 DNA polymerase (U.S. Biochemical Corp., Cleveland, OH) and the Multiwell sequencing kit (Amersham Corp., Arlington Heights, IL) or by cycle sequencing using Taq DNA polymerase (Perkin-Elmer Corp., Norwalk, CT). Cycle sequencing reactions were analyzed on a DNA sequence analyzer (model 373A;
Applied Biosystems, Inc., Foster City, CA). thymidine incorporation was determined using a direct beta counter (Matrix 9600; Packard). Lymphokine units were calculated as described (26) , and are expressed in units per ml-t. To test for experimental rather than biological variability, select assays were cultured in triplicate and supernatants were carried through separately to obtain triplicate measurements of the cytokine response per concentration point. At lymphokine concentrations below those giving the maximum proliferation of the indicator ceils, the results were essentially identical to those obtained when replicate supernatants were pooled before determining lymphokine concentrations. In addition, there were no differences in the qualitative conclusions concerning the effects of individual mutations whether lymphokine concentrations were determined from dilution curves or the counts per minute incorporated at each supernatant dilution were plotted against antigen concentration. Lymphokine unit assays, however, more accurately reflected differences in responses at high antigen concentrations.
Molecular Modeling. The MHC class II images were generated using Quanta software (Polygen Corp., Waltham, MA) on a Silicon Graphics workstation (Mountain View, CA) from coordinates corresponding to HLA-DK1 as determined by Brown et al. (20) .
Results and Discussion
Experimental Approach. Structural homologies (19, 20, (33) (34) (35) (36) and similar functions (37) of MHC class I and class II molecules suggest analogies in the mechanism of CD8-MHC class I and CD4-MHC class II interactions. Indeed, the previous identification of the class II/$2 domain's interaction with CD4 (amino acid residues 137-143) was based in part on the assumption that the binding site for CD4 might lie in a position analogous to the CD8-binding site on MHC class I molecules. An x-ray crystallographic structure had been determined for the human class I molecule, HLA-A2 (38) , and a binding site for CD8 on the ct3 domain of HLA-A2 had been identified (39) before these published CD4 studies. Although the class II/$2 domain was the predicted homologue of the class I c~3 domain, the lack of a crystallographic structure for class II at that time left open the possibility that the class II or2 domain might actually be the relevant domain for CD4 binding. Sequence alignment of the/$2 domain of MHC class II with the class I c~3 domain yielded a high degree of similarity, but alignment of the class II o~2 domain with the MHC class I-associated/$2-microglobulin was not as good. In fact, the MHC class II o~2 domain aligns better with the class I o~3 domain than with/$2-microglobulin. We therefore introduced mutations in both the class II/$2 and the ol2 domains. Analysis of mutants carrying amino acid substitutions in a surface-exposed loop of the/$2 domain rapidly revealed the presence of a critical CD4 contact site, but several clustered mutations in the o~2 domain also diminished function with CD4. We have now carefully analyzed this highly conserved second region comprising Ao~ amino acids 125-133 (numbering of residues is according to Kabat et al. [40] ).
Single or double mutations were made in an Ac~ d cDNA throughout this region. Two types of mutations were generated: human for mouse substitutions and alanine replacements. In addition, to sterically interfere with CD4-MHC class II interactions, we attempted to introduce potential N-linked glycosylation sites at positions 127 and 129 of the Ao~ a molecule. These mutants, however, were not expressed on the cell surface of transiently transfected COS or stably transfected mouse L cells. On the other hand, the corresponding control constructs carrying an asparagine residue at positions 127 or 129 and an alanine or glycine residue at positions 129 or 131, respectively, were surface expressed, and are included in this analysis.
The mutant Aot d cDNA constructs were cotransfected into L cells together with a cDNA construct encoding wildtype A/$ a and a plasmid carrying a neomycin-resistance gene. Stable transfectants were selected in G418-containing medium, and cells expressing high levels of the A a ct//$ heterodimer were isolated by antibody-mediated magnetic bead sorting.
All mutant Aot a chains included in this report supported efficient surface MHC class II expression. These mutant heterodimers reacted appropriately with a panel of monoclonal anti-A a antibodies, indicating that the mutations did not grossly affect the folding and conformation of the class II c~ chain or the assembled or3 heterodimer (data not shown).
The various transfected L cells were used as antigenpresenting cells for the stimulation of two sets of T cell hybridomas, derived from the parental lines DO.11.10 (23) and 171.3 (24) . Members of each set express the same TCR, but differ in coreceptor expression, having on their surface either human CD4 (hCD4), mouse CD4 (mCD4), mouse CD8 (mCD8), or no coreceptor at all. The DO.11.10 hybridoma responds to stimulation by APC plus peptide antigen with lymphokine secretion even in the absence of CD4 expression. It is therefore possible to selectively assess the effect of sequence changes in Aot d on the capacity of the or/3 heterodimer to elicit CD4 coreceptor function by comparing the responses to mutant vs. wild-type class II molecules of DO.11.10 cells with different coreceptor expression. Mutations with selective effects on CD4 coreceptor function but without effects on peptide binding or TCR recognition will not affect the responses of the CD4-negative T cell hybridomas, which therefore can serve as a control to render this assay independent of the precise level of dass II expression on the individual transfectant L cell lines, or of differences in the absolute level of cytokine production by the individual T hybridoma cell lines. In contrast, the 171.3 hybridoma requires CD4 expression for responses to peptide or toxin. By using transfectants with comparable levels of cell-surface MHC class II expression, the hybridoma set based on 171.3 can be used to confirm data obtained using the DO.11.10-based set of hybridomas. This is the same assay used previously to identify the CD4 interaction site on the class II/32 domain (22) .
Effects of Mutations.
In the presence of wild-type Ac~A3 d, DO.11.10 T cells expressing either hCD4 or mCD4 secreted more IL-3 than mCD8-bearing cells (Fig, 1 , A and F, and Fig. 2 A) , responding more vigorously than the mCDSexpressing line at any given dose of antigen. Substitution of glycine for serine at position 125 in the ol chain strongly reduced the response of the mCD4-expressing DO.11.10 cells at all antigen concentrations, but did not affect the response of the hCD4-bearing cells (Fig. 1 C) . This mutation is an example of an isotypic substitution at an amino acid highly conserved between alleles of a particular isotype, with serine occurring in all alleles of Aot, and glycine in Ec~ (as well as all human class II MHC isotypes). This finding is consistent with functional data suggesting CD4 interacts less well with Ec~E3 than with AccA3 (41). Another mutation of this type, substitution of serine for tyrosine at position 133, had no effect on either the hCD4 or the mCD4-expressing hybridomas (Fig. 3) . Alanine substitution at positions 129 (Fig. 2  C) and 131 (Fig. 1 D) in the oe chain substantially decreased responses from both hCD4 and mCD4-bearing cells, as did substitution of asparagine for threonine at position 129 (Figs. 1 G and 2 D), and two different double mutations also involving residue 129 (Figs. 1 H, 2 E, and 3) . In contrast, the capacity of these mutants to elicit responses from the mCD8-expressing DO.11.10 cells remained wild type-like. As a comparison, we have included the previously described double alanine mutation in the AaB2 domain at positions 137 and 142 (Fig. 1J) , which abrogates CD4 coreceptor function in this assay (22) . Mutations decreasing CD4 function in these DO.11.10 experiments also reduced cytokine production by both hCD4-and mCD4-expressing 171.3 cells relative to stimulation with wild-type ActA/~ molecules (Fig. 1, K-N) .
Asparagine substitution of threonine 129 drastically reduced function with both hCD4 and mCD4 (Figs. 1 G and 2 D) . (Fig. 2) . This experiment demonstrated the major contribution of the alanine for serine substitution at 125 to the decrease in function with hCD4, and the equivalency of alanine and asparagine substitutions at 129.
The effects of mutations in the ol2 domain of I-A a appeared greatest at low to moderate antigen concentrations. Mutations judged to decrease function with CD4 reduced responses by CD4 + T hybridomas to a level equal or only slightly higher than that seen with the mCD8 + control hybridoma cells. As seen in some of the antigen dose-response curves depicted in Fig. 1 , the effects of a partial loss of MHC class II-induced CD4 function could be overcome at very high antigen concentrations. To standardize data from multiple experiments in which absolute responses varied, we used a transformation formula that accounts for the range in the dose-response curve covered by low to moderate antigen concentrations. This formula gives an estimate of the residual CD4 coreceptor function induced by the respective mutant AotdA~ d molecule with wild type-like function represented by a fractional value of 1 and a value of 0 given to mutant AotdA/~ d molecules that fail to induce an increased response by the CD4 + T hybridoma ceUs as compared with the CD8 + control calls. The fractional CD4 coreceptor function was defined as: F = log f [mutant Ac~aABd]/log f [Ac~dABd]; wherefrepresents the ratio between the antigen concentration necessary to half-maximally stimulate the CD8 + control T hybridoma and the antigen concentration required to cause equal cytokine secretion by T hybridoma cells bearing either mCD4 or hCD4. Fig. 3 summarizes the results of several independent experiments of the type illustrated in Figs. 1 and 2 using the transformation formula just described. In each individual experiment, this formula attributes a value of F = 1 to wildtype Ao~dA/3 d. The shaded area in the panels of Fig. 3 represents the range of F values seen in repeated experiments with mutations we judge to have wild-type function with CD4, because they led to only small effects of inconsistent direction (e.g., 0.78-1.1 for $127T with mCD4; 0.96-1.18 for V132A with mCD4). Bars that do not reach these shaded areas or extend beyond them therefore identify mutations that consistently affect function with CD4 in a single direction (decrease or increase, respectively) and to an extent greater than the experimental variability in this system. The data indicate that amino acids 125-131 of Ac~ are part of a site necessary for optimal class II-dependent CD4 coreceptor function. Threonine 129 appeared to be particularly important for mediating this interaction, because both alanine substitution and the relatively conservative asparagine replacement drastically reduced function with both hCD4 and mCD4. Glycine for serine substitution at position 125 drastically reduced function with mCD4, but did not affect function with hCD4. On the other hand, alanine for serine substitution at 125 affected function with both. The differential effect of glycine vs. alanine at position 125 on human CD4 vs. mouse CD4 function could reflect the coevolution of the human coreceptor and class II for proper interaction involving this site directly. Alternatively, structural data indicate that residues 125-133 are part of a surface-exposed loop between the C and D strands of the o~2 domain (20) (Fig. 4 A) . Both ends of this loop are defined by glycines in most class II molecules, and mutating residues 125 and 131 may affect the overall conformation of the loop. Several of the substitutions augmented function with CD4. For example, substitution of serine for tyrosine 133 strongly enhanced function with both mouse and human CD4. Serine is the amino acid occurring at this position in all alleles of HLA-DK and DQ, whereas tyrosine at this position is conserved among alldes of I-A. The increase in function resulting from the serine for tyrosine substitution may be a reflection 2111111" of the higher affinity of human CD4 for human class II compared to mouse CD4 and mouse class II (21, 42) , and the contribution of serine at this position to stronger binding between these proteins. A simple structural explanation is not as readily apparent for the ability of conservative substitutions $127T and V128A to sdectivdy enhance function with human but not mouse CD4.
Structural and Functional Implications.
Computer docking studies show that the dongated, rigid structure of the CD4 D1 and D2 domains involved in interaction with class II (43, 44) and the positioning of the 132 and a2 sites on opposite faces of the class II heterodimer (Fig. 4 A) prevent these critical binding regions of single CD4 molecules from simultaneously interacting with both sites on an individual class II molecule (Fleury, S., and R. N. Germain, unpublished observations). Yet the ability of either a or B chain mutations to strongly decrease the capacity of class II molecules to support CD4 function indicates that both sites are required for inducing full CD4 coreceptor activity. Together, these observations provide the first evidence that during T cell activation by physiological ligands, CD4 and class II molecules must undergo a structurally precise dimerization or oligo-783 Krnig et al.
merization for the effective contribution of CD4 to receptordependent signal transduction. Two different general models for the organization of the CD4-class II complex can be envisioned that satisfy the structural constraints revealed by this study and the available data on CD4 regions affecting interaction with class II (44) . In the first model, two CD4 molecules would associate with a single TCR-MHC class II complex, one CD4 molecule binding to the a2 site and the other to the/32 site ( Fig. 5 A) . The two CD4 molecules thus would form a damp tethering the class II ligand to the TCR. This would also provide a mechanism for activating the protein tyrosine kinase, p56 k~, upon monovalent TCR-MHC class II interaction, based on CD4 dimerization in this postulated complex. Furthermore, higher order oligomerization of the coreceptor-TCR-MHC class II units might occur, if the free face of each CD4 molecule could engage the alternative site of an adjacent, TCRengaged class II molecule (Fig. 5 B) . This model is consistent with data suggesting that two opposite surfaces of the D1-D2 segment of CD4 contribute to class II recognition (44) , and with the possible role of such higher order oligomers ("immunons") in lymphocyte signal transduction (45) . An intriguing alternative model comes from recognizing that the or2 and B2 sites lie in close proximity on a single face of the dimer of dimers observed in crystals of the human class II HLA-DR1 molecule (20) (Fig. 4 B) . In this configuration, the two discontinuous sites on a single class II dimer would now contribute to a single surface for interaction with CD4, possibly supporting a higher binding affinity than either site alone. CD4 would thus stabilize the interaction of the two heterodimer units of the class II "superdimer" and that of the associated pair of TCR complexes (Fig. 5 C) . The mapping of regions contributing to CD4-class II interaction to discrete faces of CD4 might then reflect the presence of the actual binding surface on one face, and a possible dimerization interface on the other, that could link TCRsuperdimer complexes into large oligomers.
A large body of literature derived primarily from antibody cross-linking experiments supports the importance ofcoclustering or coaggregation of CD4 and TCR for effective T cell activation, but these prior studies provided no information on the specific molecular associations necessary for proper signaling during physiological call-cell interaction (6, 7, 15) . The identification here of a second discrete binding site for CD4 on class II molecules strongly suggests that structurally specific, ordered oligomerization as opposed to generalized colocalization is a key feature in the assembly of useful signal transduction complexes on T cells. This result extends to the T cell receptor-coreceptor complex the general principle of ligand-induced receptor dimerization/oligomerization as a key event in the initiation of transmembrane signaling (46) . The critical role of these stable, properly assembled dimers or oligomers in T cell activation also suggests that the partial agonist or antagonist properties of variant TCR-MHC:peptide complexes (47-49) may result from improper formation or altered stability of these critical molecular assemblies (50) (51) (52) (53) . 
